514 Episodes

  1. S8 Ep27: Milner, Dalal, and Ligon Discuss Stem Cell Transplant Methods, Results, and Risk Factors in Pediatric Patients

    Published: 3/13/2023

  2. S8 Ep26: FDA Approval Insights: Adjuvant Pembrolizumab in Stage IB, II, or IIIA NSCLC

    Published: 3/9/2023

  3. S8 Ep25: CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice

    Published: 3/6/2023

  4. S8 Ep24: Jakubowiak Highlights PFS Benefit Seen With KRd Maintenance in Newly Diagnosed Multiple Myeloma

    Published: 3/2/2023

  5. S8 Ep23: FDA Approval Insights: Pirtobrutinib in MCL

    Published: 2/27/2023

  6. S8 Ep22: Mascarenhas Summarizes Therapeutic Standards and Advances in Myelofibrosis Management

    Published: 2/23/2023

  7. S8 Ep21: FDA Approval Insights: Zanubrutinib in CLL and SLL

    Published: 2/16/2023

  8. S8 Ep20: Small and Reagan Review Tumor Lysis Syndrome Risk Factors and Management Strategies

    Published: 2/13/2023

  9. S8 Ep19: D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

    Published: 2/9/2023

  10. S8 Ep19: FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC

    Published: 2/6/2023

  11. S8 Ep18: Rosenthal Discusses the Need for Standardized Care in AYA Hodgkin Lymphoma

    Published: 2/2/2023

  12. S8 Ep17: Nair Notes the Benefits of Yoga as a Complementary Therapy in Nonmetastatic Breast Cancer

    Published: 1/30/2023

  13. S8 Ep17: FDA Approval Insights: Nadofaragene Firadenovec in BCG-Unresponsive NMIBC

    Published: 1/26/2023

  14. S8 Ep16: Goetz and Choong Describe the Need for Adjuvant Endocrine Therapy in ER-positive Breast Cancer 

    Published: 1/23/2023

  15. S8 Ep15: Dy Discusses CEACAM5-Directed and Other Second-Line Treatment Strategies in NSCLC

    Published: 1/19/2023

  16. S8 Ep14: Giacchetti Discusses the Convergence of Chronobiology and Oncologic Care in Breast Cancer

    Published: 1/16/2023

  17. S8 Ep14: Hilal Highlights BTK Inhibitor Research and Implications of MRD Negativity in CLL

    Published: 1/12/2023

  18. S8 Ep12: Breast Cancer Experts Review HR+ Treatment Updates From SABCS 2022

    Published: 1/5/2023

  19. S8 Ep11: Oppong Emphasizes How Patient Education Can Lower Breast Cancer Surgery Refusal Rates

    Published: 1/2/2023

  20. S8 Ep10: Somaiah Shares Insight on the Changing Landscapes of GIST, TGCT, and RAS/RAF-Mutant Tumors

    Published: 12/29/2022

18 / 26